Bucher James B 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Oct 1, 2025
Insider Transaction Report
Form 4
Bucher James B
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+400,000→ 400,000 totalExercise: $1.54Exp: 2025-09-30→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The options will vest over a four-year period as follows: 25% of the options will vest on October 1, 2026, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.